In terms of the fission-related Drp1 protein, it has been shown that activation and enhanced expression of Drp1 enhances cancer cell proliferation, survival and drug resistance to melanoma-targeted therapies3, 28, 53, 54. The gene discussed is DNM1L; the disease is melanoma.